21-31038380-C-T
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_001099219.1(KRTAP19-8):c.64G>A(p.Gly22Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000856 in 1,612,782 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/20 in silico tools predict a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Consequence
NM_001099219.1 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
KRTAP19-8 | NM_001099219.1 | c.64G>A | p.Gly22Ser | missense_variant | 1/1 | ENST00000382822.2 | NP_001092689.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
KRTAP19-8 | ENST00000382822.2 | c.64G>A | p.Gly22Ser | missense_variant | 1/1 | 6 | NM_001099219.1 | ENSP00000372272.2 |
Frequencies
GnomAD3 genomes AF: 0.000132 AC: 20AN: 152064Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000111 AC: 28AN: 251162Hom.: 0 AF XY: 0.000125 AC XY: 17AN XY: 135768
GnomAD4 exome AF: 0.0000808 AC: 118AN: 1460600Hom.: 0 Cov.: 29 AF XY: 0.0000853 AC XY: 62AN XY: 726732
GnomAD4 genome AF: 0.000131 AC: 20AN: 152182Hom.: 0 Cov.: 32 AF XY: 0.000148 AC XY: 11AN XY: 74412
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 08, 2024 | The c.64G>A (p.G22S) alteration is located in exon 1 (coding exon 1) of the KRTAP19-8 gene. This alteration results from a G to A substitution at nucleotide position 64, causing the glycine (G) at amino acid position 22 to be replaced by a serine (S). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at